Javascript must be enabled to continue!
Success Rate of Thorax Ultrasonography in Assisting Thoracocentesis Action in Clinical Pulmonary Tuberculosis at Respira Lung Hospital Yogyakarta
View through CrossRef
The use of X-ray Thorax (XCR Thorax) in assisting thoracocentesis procedures has some limitations. XCR Thorax only provides a two-dimensional image, which may limit the accuracy in determining the exact location for the puncture. In addition, XCR Thorax cannot detect septation or loculation which may affect the success of the thoracocentesis procedure. Thoracic ultrasonography offers advantages in detecting pleural effusion compared to conventional radiographic methods, but has not been standardized in national guidelines. This study aims to see the difference in the success rate of thoracocentesis between the use of thoracic ultrasound guidance and thoracic photo guidance in patients with clinical tuberculosis at Respira Lung Hospital Yogyakarta. This cross-sectional study used a static group comparison approach to compare the success rate of thoracocentesis between two groups at Respira Lung Hospital Yogyakarta: 30 patients with Thorax ultrasound and Thorax photo guidance (Group A) and 30 patients only with Thorax photo guidance (Group B). With a purposive sampling method and analysis using the chi-square test, this study aims to analyze differences in the success rate of thoracocentesis in real clinical conditions without intervening in existing procedures in the hospital. Thoracocentesis with thorax photo plus thorax ultrasound guidance showed a success rate of 100% compared to 66.67% in procedures with thorax X-ray alone (p < 0.001). The results showed that the use of thoracic ultrasound as a thoracocentesis guide had a higher success rate compared to the use of thoracic photo guidance.
Asosiasi Penelitian dan Pengajar Ilmu Hukum Indonesia
Title: Success Rate of Thorax Ultrasonography in Assisting Thoracocentesis Action in Clinical Pulmonary Tuberculosis at Respira Lung Hospital Yogyakarta
Description:
The use of X-ray Thorax (XCR Thorax) in assisting thoracocentesis procedures has some limitations.
XCR Thorax only provides a two-dimensional image, which may limit the accuracy in determining the exact location for the puncture.
In addition, XCR Thorax cannot detect septation or loculation which may affect the success of the thoracocentesis procedure.
Thoracic ultrasonography offers advantages in detecting pleural effusion compared to conventional radiographic methods, but has not been standardized in national guidelines.
This study aims to see the difference in the success rate of thoracocentesis between the use of thoracic ultrasound guidance and thoracic photo guidance in patients with clinical tuberculosis at Respira Lung Hospital Yogyakarta.
This cross-sectional study used a static group comparison approach to compare the success rate of thoracocentesis between two groups at Respira Lung Hospital Yogyakarta: 30 patients with Thorax ultrasound and Thorax photo guidance (Group A) and 30 patients only with Thorax photo guidance (Group B).
With a purposive sampling method and analysis using the chi-square test, this study aims to analyze differences in the success rate of thoracocentesis in real clinical conditions without intervening in existing procedures in the hospital.
Thoracocentesis with thorax photo plus thorax ultrasound guidance showed a success rate of 100% compared to 66.
67% in procedures with thorax X-ray alone (p < 0.
001).
The results showed that the use of thoracic ultrasound as a thoracocentesis guide had a higher success rate compared to the use of thoracic photo guidance.
Related Results
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Abstract
Background :Tuberculosis (TB) is a major public health concern worldwide and is the 13th leading cause of death and the second deadliest infectious disease after C...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

